Prediction of Adeno-Associated Virus Neutralizing Antibody Activity for Clinical Application

Patients with neutralizing antibodies (Nab) against adeno-associated virus (AAV) are usually excluded from treatment with AAV vectors. To develop a standard assay for detecting Nab inhibition activity, we systematically studied current AAV Nab assays in vitro and in vivo. Several factors were found...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Mei, Crosby, Ashley, Hastie, Eric, Samulski, Jade J., McPhee, Scott, Joshua, Grieger, Samulski, R. Jude, Li, Chengwen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2015
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4670282/
https://www.ncbi.nlm.nih.gov/pubmed/26125606
http://dx.doi.org/10.1038/gt.2015.69

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4670282/
https://www.ncbi.nlm.nih.gov/pubmed/26125606
http://dx.doi.org/10.1038/gt.2015.69

Ejemplares similares